Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).

被引:2
作者
Ghatalia, Pooja
Handorf, Elizabeth A.
Deng, Mengying
Zibelman, Matthew R.
Abbosh, Philip
Anari, Fern
Greenberg, Richard E.
Viterbo, Rosalia
Chen, David
Smaldone, Marc C.
Kutikov, Alexander
Geynisman, Daniel M.
Uzzo, Robert Guy
机构
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] FCCC, Philadelphia, PA USA
[3] Fox Chase Canc Ctr, Dept Hematol & Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA
关键词
D O I
10.1200/JCO.2021.39.15_suppl.4582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4582
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03) : 453 - 454
  • [32] Cytoreductive nephrectomy for metastatic renal cell carcinoma – obsolete?
    Grimm M.-O.
    Der Urologe, 2019, 58 (1): : 51 - 52
  • [34] Impact of cytoreductive nephrectomy (CN) on survival in metastatic renal cell cancer (mRCC) treated with immune checkpoint inhibitors (ICI).
    Perimbeti, Stuthi
    Jiang, Changchuan
    Deng, Lei
    Roy, Arya
    Gopalakrishnan, Keerthy
    Chatta, Gurkamal S.
    George, Saby
    Gopalakrishnan, Dharmesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [35] Role of cytoreductive nephrectomy in renal cell carcinoma
    Chiong, Edmund
    Wood, Christopher G.
    Margulis, Vitaly
    FUTURE ONCOLOGY, 2009, 5 (06) : 859 - 869
  • [36] Partial cytoreductive nephrectomy versus cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Vitruk, Iurly
    Stakhovskyi, Oleksandr
    Voylenko, Oleg
    Kotov, Volodymyr
    Pikul, Maxim
    Stakhovsky, Eduard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Lapaloscopic cytoreductive nephrectomy for metastatic renal cell carcinoma
    Fujita, T.
    Hattori, R.
    Kinukawa, T.
    Ono, Y.
    JOURNAL OF ENDOUROLOGY, 2006, 20 : A231 - A231
  • [38] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma PRO
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2013, 190 (02) : 387 - 388
  • [39] Long-term survival of patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy (TT) without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Tamboli, P.
    Patel, K.
    Matin, S. F.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [40] Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME)
    Bex, A.
    Mulders, P.
    Jewett, M. A. S.
    Wagstaff, J.
    van Velthoven, R.
    Pes, P. M. Laguna
    Wood, L.
    van Melick, H. H. E.
    Soetekouw, P.
    Lattouf, J. B.
    Powles, T.
    Boleti, E.
    de Jong, I-J.
    Rottey, S.
    Tombal, B.
    Marreaud, S.
    Collette, L.
    Collette, S.
    Blank, C. U.
    Haanen, J. B.
    ANNALS OF ONCOLOGY, 2017, 28